Research programme: hyperbranched polyglycerol-based therapeutics - Sitka BiopharmaAlternative Names: HPG-docetaxel
Latest Information Update: 12 Dec 2013
At a glance
- Originator Sitka Biopharma
- Class Glycerols
- Mechanism of Action Mitosis inhibitors; Tubulin modulators; Tubulin polymerisation promoters
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Bladder cancer
Most Recent Events
- 03 Dec 2013 Preclinical trials in Bladder cancer in Canada (Intravesicular instillation)